Tag: CBT > DEA Cannabis Policy and Legalization

Cannabis Rescheduling

DEA’s Schedule III Cannabis Registration ‘Coming Soon’ For Cultivators, Manufacturers, Distributors, Labs

The application for non-dispensary businesses to handle Schedule III medical cannabis will be available in the coming weeks.

May 11, 2026

Cannabis Rescheduling

DEA Schedule III Registration Asks Cannabis Businesses to Admit to Drug Trafficking

State-licensed medical cannabis businesses have 60 days to apply for the federal registration to receive an expedited review; providing false info is punishable by jail.

April 30, 2026

Cannabis Rescheduling

When Polarization Replaces Governance: Cannabis Rescheduling and the Cost of Fear-Based Leadership (Opinion)

Much of the industry conversation to Trump’s executive order defaults to doom narratives that generate engagement but produce minimal legislative leverage.

December 22, 2025

Cannabis Rescheduling

Industry Stakeholders, Experts React to Trump’s Schedule III Cannabis Order

Business executives, advocates, attorneys, politicians, and ancillary service providers overwhelmingly applaud the order as a first step, not an end destination.

December 19, 2025

Cannabis Rescheduling

UPDATE: US Senate Confirms Trump’s DEA Administrator Pick

After the Senate invoked cloture, Terrance Cole was confirmed as the Drug Enforcement Administration’s next leader.

July 18, 2025

Cannabis Rescheduling

Doctors Ask US Appellate Court for Redo in DEA’s Selections for Cannabis Rescheduling Participants

Doctors for Drug Policy Reform argues the DEA’s selections were arbitrary and capricious, providing ‘cure letters’ as evidence of ex parte communications.

February 18, 2025

Cannabis Rescheduling

DEA Judge Sends Interlocutory Appeal to Administrator; Recommends All Participants Be Included

The judge asked DEA Administrator Anne Milgram to include all designated participants for the cannabis rescheduling hearing to be part of a briefing schedule.

January 16, 2025

Cannabis Rescheduling

Interlocutory Appeal Could Derail Cannabis Rescheduling Hearing

New evidence prompted rescheduling advocates’ second effort to oust the DEA from the hearing; if relief is denied, they will seek the appeal.

January 8, 2025

Top Stories

DEA Names 25 Participants for Cannabis Rescheduling Hearing That’s Now Delayed Until 2025

An administrative law judge issued an order pushing back testimonies until January or February.

November 1, 2024

Cannabis Industry Research

Medical Marijuana Act Signed by Biden Would Hinder Research Under Rescheduling

The Medical Marijuana and Cannabidiol Research Expansion Act’s requirements would remain under Schedule III, a congressional researcher says.

September 20, 2024

Cannabis Advertising

The Complex Impact of Rescheduling Cannabis on Advertising

The penalties for advertising Schedule I drugs don’t apply to Schedule III drugs, but cannabis businesses could be left in a precarious position.

September 17, 2024

Industry Headlines

MMJ BioPharma Suing DEA Over Cannabis Reform, Medical Research

The biopharmaceutical company filed a lawsuit, citing ‘unjustified’ delays in processing an application for medical research.

September 11, 2024